Several proteins involved in this pathway are associated with breast cancer prognosis (including ERCC6 and POSTN34,35) and/or sensitivity/resistance to endocrine or other chemotherapy (including EGFR, ABL1, GNA13, and PTK736–39). Here, ABL1 is linked to breast carcinoma.